Please provide your email address to receive an email when new articles are posted on . The PHQ-9M for teens includes four additional questions about depression and suicidal ideation. The extra ...

Once-weekly subcutaneous tirzepatide may not raise risk for depression compared with placebo, according to a post hoc analysis of the SURMOUNT trials. As Healio previously reported, in January the FDA ...

Implementing the Patient Health Questionnaire-2 (PHQ-2) in a hidradenitis suppurativa (HS) clinic improved the ability of dermatologists to detect patients at risk for depression, results from a ...